Results of a Randomized placebo-controlled study of memory training for mildly impaired Alzheimer's disease patients

被引:69
|
作者
Cahn-Weiner, DA
Malloy, PF
Rebok, GW
Ott, BR
机构
[1] Brown Med Sch, Dept Psychiat & Human Behav, Providence, RI USA
[2] Mem Hosp Rhode Isl, Pawtucket, RI USA
[3] Butler Hosp, Providence, RI 02906 USA
[4] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[5] Brown Med Sch, Dept Clin Neurosci, Providence, RI USA
来源
APPLIED NEUROPSYCHOLOGY | 2003年 / 10卷 / 04期
关键词
memory training; Alzheimer's Disease; randomized placebo-controlled;
D O I
10.1207/s15324826an1004_3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The efficacy of a memory-training program to improve word-list recall and recognition was evaluated in 34 patients with probable Alzheimer's disease (AD). The patients, who were all taking donepezil throughout the 6-week intervention, were randomly assigned to a cognitive intervention group or a control group. The Control group received didactic presentations but no formal memory training. Patients were assessed on neuropsychological tests before the 6-week training program, immediately after the training, and 8 weeks after completion of the training. Caregivers, who were blind to group assignment, completed activities of daily living (ADLs) and everyday memory questionnaires at all three timepoints. No significant main effects of group (training vs. control) or time were observed on any outcome measures, nor were any significant interactions found. In terms of "process" measures during the 6-week training program, the patients demonstrated modest improvement on recall and recognition of test material presented during the training sessions. These results suggest that although modest gains in learning and memory may be evident in AD patients who are taught specific strategies, the benefits do not generalize to other measures of neuropsychological functioning after a brief intervention.
引用
收藏
页码:215 / 223
页数:9
相关论文
共 50 条
  • [1] Aripiprazole for the treatment of psychosis in patients with Alzheimer's Disease - A randomized, placebo-controlled study
    De Deyn, P
    Jeste, DV
    Swanink, R
    Kostic, D
    Breder, C
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (05) : 463 - 467
  • [2] Transcranial direct current stimulation as a memory enhancer in patients with Alzheimer’s disease: a randomized, placebo-controlled trial
    Martin Bystad
    Ole Grønli
    Ingrid Daae Rasmussen
    Nina Gundersen
    Lene Nordvang
    Henrik Wang-Iversen
    Per M. Aslaksen
    Alzheimer's Research & Therapy, 8
  • [3] Transcranial direct current stimulation as a memory enhancer in patients with Alzheimer's disease: a randomized, placebo-controlled trial
    Bystad, Martin
    Gronli, Ole
    Rasmussen, Ingrid Daae
    Gundersen, Nina
    Nordvang, Lene
    Wang-Iversen, Henrik
    Aslaksen, Per M.
    ALZHEIMERS RESEARCH & THERAPY, 2016, 8
  • [4] Cognitive intervention in Alzheimer disease: a randomized placebo-controlled study
    Davis, RN
    Massman, PJ
    Doody, RS
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2001, 15 (01): : 1 - 9
  • [5] A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ANAKINRA IN PATIENTS WITH STILL′S DISEASE
    Schanberg, L.
    Nigrovic, P.
    Cooper, A.
    Chatham, W.
    Akoghlanian, S.
    Singh, N.
    Rabinovich, E.
    Thatayatikom, A.
    Taxter, A.
    Hausmann, J.
    Zdravkovic, M.
    Ohlman, S.
    Andersson, H.
    Cederholm, S.
    Wiken, M.
    Schneider, R.
    De Benedetti, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1815 - 1816
  • [6] Effects of Cerebrolysin on neuropsychiatric symptoms in Alzheimer's disease: results of a randomized, placebo-controlled trial
    Alvarez, A.
    Cacabelos, R.
    Couceiro, V.
    Aleixandre, M.
    Doppler, E.
    Novak, P.
    Moessler, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 72 - 72
  • [7] Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease
    Herrmann, Nathan
    Ruthirakuhan, Myuri
    Gallagher, Damien
    Verhoeff, Nicolaas Paul L. G.
    Kiss, Alex
    Black, Sandra E.
    Lanctot, Krista L.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 27 (11): : 1161 - 1173
  • [8] Results of a randomized, double-blind, placebo-controlled trial with the neurotrophic compound cerebrolysin in Alzheimer's disease patients
    Alvarez, A
    Laredo, M
    Sampedro, C
    Cacabelos, R
    Couceiro, V
    Vargas, M
    Aleixandre, M
    Illescas, E
    Linares, C
    Granizo, E
    Moessler, H
    NEUROBIOLOGY OF AGING, 2004, 25 : S209 - S209
  • [9] SAFETY OF INTRAVENOUS IMMUNOGLOBULIN THERAPY IN PATIENTS WITH PROBABLE ALZHEIMER'S DISEASE: A RANDOMIZED, PLACEBO-CONTROLLED CLINICAL STUDY
    Gelmont, D.
    Thomas, R. G.
    Dyck-Jones, J. A.
    Fritsch, S.
    Aisen, P.
    Relkin, N.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A113 - A113
  • [10] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Teprenone in Patients with Alzheimer's Disease
    Yokoyama, Shunichi
    Yoshinaga, Takuma
    Matsuzaki, Juntaro
    Suzuki, Hidekazu
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 71 (04) : 1187 - 1199